Skip to content

Dosimetry Check 4

by Math Resolutions, LLC

Dosimetry Check 4 is a Class II device made by Math Resolutions, LLC, cleared under FDA 510(k) K132605 on 14 Nov 2013 (2 earlier submissions) and listed in FDA GUDID since 17 Jun 2016 (UDI-DI B229DC041), active as of 23 Oct 2026.

Active United States. Also listed in GUDID (US).

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 23 Oct 2026

Documents

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing NumberB229DC041 UDI-DI Date17 Jun 2016ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k)SESE from GUDID Substantially Equivalent · Traditional NumberK132605 Date14 Nov 2013DecidedStatusActive

Official records

Across registries

2 registries list this device

  • FDA 510(k) K132605 decided 14 Nov 2013 Active· +2 more in the status table
  • FDA GUDID UDI-DI B229DC041 listed 17 Jun 2016 Listed

Timeline

4 dated events

  1. Cleared FDA 510(k) K010225
  2. Cleared FDA 510(k) K101503
  3. Cleared FDA 510(k) K132605
  4. Listed FDA GUDID B229DC041

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

GUDID

Trade name
Dosimetry Check
Generic name
Radiation therapy software
Model / reference
4
Primary DI / UDI-DI
B229DC041
FDA product code
IYE
GMDN term
Radiation therapy software
Device class
Class II
Regulation number
892.5050
GUDID distribution status
In Commercial Distribution

Similar devices in this category

Other devices filed under Radiation therapy software.

Other devices from Math Resolutions, LLC

  • Dosimetry Check 5

    Class II
  • MillComp 1

    Class II
  • RtDosePlan 2

    Class II
  • MarkRT 2

    Class II

See all devices from Math Resolutions, LLC →

Properties

  • Serial number
  • Manufacturing date
Other properties (13, all answered No)